The purpose of the study: obtaining knowledge about the impact of Snoezelen® therapy on the health of adults suffering from schizophrenia and requiring permanent institutional care, adults suffering from schizophrenia and adults (women) addicted to alcohol.
The main questions it aims to answer are:
Does Snoezelen therapy improve the health of adults suffering from schizophrenia and requiring permanent institutional care, adults suffering from schizophrenia and adults (women) addicted to alcohol?
The participant will participate in Snoezelen® therapy for 6 or 12 weeks, 2 times a week (30 minutes each session).
Adults suffering from schizophrenia requiring permanent institutional care, N=40
women and men aged ≥ 18 years,
consent of the patient or legal guardian to participate in the study,
schizophrenia clinically confirmed for at least 5 years, with predominance of negative symptoms,
lack of consent to participate in the study;
pregnancy;
general contraindications (acute inflammatory and febrile diseases, venous thrombosis, unstable arterial hypertension, early condition after contrast computed tomography, early condition after lumbar puncture, general serious condition of the patient);
unstable or untreated epilepsy, based on EEG;
Parallel
Snoezelen® therapy for 6 weeks
Other interventionThe each session of Snoezelen® therapy will last 30 minutes and will include: 1. preparation and adjustment of stimuli based on information regarding the assessment of the patient's condition and problems, 2. careful observation and appropriate care of the patient, 3. grading of stimuli and their appropriate stimulation, 4. experiencing therapeutic activities together with the patient, 5. recording the therapist's presence and comments on the therapy card.
Snoezelen® therapy for 12 weeks
Other interventionDescription: The each session of Snoezelen® therapy will last 30 minutes and will include: a) preparation and adjustment of stimuli based on information regarding the assessment of the patient's condition and problems, b) careful observation and appropriate care of the patient, c) grading of stimuli and their appropriate stimulation, d) experiencing therapeutic activities together with the patient, e) recording the therapist's presence and comments on the therapy card.
outcomes in patients suffering from schizophrenia requiring institutional care - MOCA or ACE-III
1\. Cognitive function testing using the MOCA or ACE-III * The Montreal Cognitive Assessment (MOCA) assesses cognitive function. The test consists of 30 tasks assessing language, memory, reasoning, orientation, visual reasoning, and spatial reasoning. The test takes approximately 10-15 minutes to complete. Maximum score: 30 points. One point is added for individuals with less than 12 years of education. * The Addenbrooke's Cognitive Examination III (ACE-III) is an extended screening tool for cognitive function. The test assesses attention and orientation, memory, verbal fluency, language, and visuospatial functions. The test takes approximately 15 minutes. The maximum score is 100 points. A score below 88 suggests the presence of cognitive impairment and requires further medical evaluation.
outcomes in patients suffering from schizophrenia requiring institutional care - BDI or GDS
Emotional state examination, which will be carried out by determining the degree of: a. Severity of depressive symptoms using the BDI or GDS scale. * The Beck Depression Inventory (BDI) measures the severity of depression symptoms, which includes questions about mood, guilt, and physical symptoms. A score of 0 to 10 indicates no depression, 11 to 27 indicates mild or moderate depression, and 28 or more indicates severe depression. * The GDS-30 (Geriatric Depression Scale) is a screening tool used to assess the severity of depression symptoms in older adults. GDS-30 consists of 30 questions about well-being over the past week. 0-9 points: normal condition (no symptoms of depression); 10-19 points: suspicion of moderate depression; \>20 points: suspicion of severe depression.
outcomes in patients suffering from schizophrenia requiring institutional care - Burns Anxiety Inventory
Emotional state examination, which will be carried out by determining the b. Anxiety levels using the Burns Anxiety Inventory The questionnaire consists of 33 questions divided into three main categories, which the patient rates based on their experience over the past week: Anxious feelings - 6 items (e.g., nervousness, sense of impending doom, panic attacks). Anxious thoughts - 11 items (e.g., fear of losing control, fear of going crazy or becoming physically ill). Physical symptoms - 16 items (e.g., heart palpitations, dizziness, muscle tension, shortness of breath). Scoring: Each of the 33 questions is rated on a 4-point Likert scale from 0 to 3 points: 0 - Not at all / did not bother 1 - A little / slightly 2 - Moderate 3 - Very much. The total score ranges from 0 to 99 points. Interpretation of results: 0-4 points: Minimal or no anxiety, 5-10 points: Anxiety very mild, 11-20 points: Mild anxiety, 21-30 points: Moderate anxiety, 31-50 points: Severe anxiety.
outcomes in patients suffering from schizophrenia requiring institutional care - SWLS
Life satisfaction using the SWLS scale The SWLS (Satisfaction with Life Scale) is a short psychological tool used to assess overall life satisfaction. It consists of five statements, which the respondent rates on a seven-point scale. It is intended for adults, both healthy and sick, and takes approximately two minutes to complete. The scasle contains five statements regarding satisfaction with one's overall life. Response Format: Seven-point Likert scale (from 1 - I completely disagree to 7 - I completely agree). Score: overall life satisfaction index = the higher the score, the greater the sense of satisfaction.
Click on the lead sponsor to view all of their trials.
The Jerzy Kukuczka Academy of Physical Education in Katowice
Lead sponsor
Clinical Psychiatric Hospital SPZOZ in Rybnik, Poland
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
